507 related articles for article (PubMed ID: 34437646)
1. Associations of fat mass and muscle function but not lean mass with cognitive impairment: The Yishun Study.
Tou NX; Wee SL; Pang BWJ; Lau LK; Jabbar KA; Seah WT; Chen KK; Ng TP
PLoS One; 2021; 16(8):e0256702. PubMed ID: 34437646
[TBL] [Abstract][Full Text] [Related]
2. Relationship of Fat Mass Index and Fat Free Mass Index With Body Mass Index and Association With Function, Cognition and Sarcopenia in Pre-Frail Older Adults.
Merchant RA; Seetharaman S; Au L; Wong MWK; Wong BLL; Tan LF; Chen MZ; Ng SE; Soong JTY; Hui RJY; Kwek SC; Morley JE
Front Endocrinol (Lausanne); 2021; 12():765415. PubMed ID: 35002957
[TBL] [Abstract][Full Text] [Related]
3. Associations Between Muscle Quality and Cognitive Function in Older Men: Cross-Sectional Data From the Geelong Osteoporosis Study.
Sui SX; Williams LJ; Holloway-Kew KL; Hyde NK; Leach S; Pasco JA
J Clin Densitom; 2022; 25(2):133-140. PubMed ID: 33879389
[TBL] [Abstract][Full Text] [Related]
4. Physical function-derived cut-points for the diagnosis of sarcopenia and dynapenia from the Canadian longitudinal study on aging.
Tessier AJ; Wing SS; Rahme E; Morais JA; Chevalier S
J Cachexia Sarcopenia Muscle; 2019 Oct; 10(5):985-999. PubMed ID: 31307126
[TBL] [Abstract][Full Text] [Related]
5. Sarcopenia-related features and factors associated with low muscle mass, weak muscle strength, and reduced function in Chinese rural residents: a cross-sectional study.
Xu HQ; Shi JP; Shen C; Liu Y; Liu JM; Zheng XY
Arch Osteoporos; 2018 Dec; 14(1):2. PubMed ID: 30560296
[TBL] [Abstract][Full Text] [Related]
6. The Copenhagen Sarcopenia Study: lean mass, strength, power, and physical function in a Danish cohort aged 20-93 years.
Suetta C; Haddock B; Alcazar J; Noerst T; Hansen OM; Ludvig H; Kamper RS; Schnohr P; Prescott E; Andersen LL; Frandsen U; Aagaard P; Bülow J; Hovind P; Simonsen L
J Cachexia Sarcopenia Muscle; 2019 Dec; 10(6):1316-1329. PubMed ID: 31419087
[TBL] [Abstract][Full Text] [Related]
7. Handgrip strength and muscle quality in Australian women: cross-sectional data from the Geelong Osteoporosis Study.
Sui SX; Holloway-Kew KL; Hyde NK; Williams LJ; Tembo MC; Mohebbi M; Gojanovic M; Leach S; Pasco JA
J Cachexia Sarcopenia Muscle; 2020 Jun; 11(3):690-697. PubMed ID: 32061063
[TBL] [Abstract][Full Text] [Related]
8. Obesity Measures and Definitions of Sarcopenic Obesity in Singaporean Adults - the Yishun Study.
Pang BWJ; Wee SL; Lau LK; Jabbar KA; Seah WT; Ng DHM; Tan QLL; Chen KK; Jagadish MU; Ng TP
J Frailty Aging; 2021; 10(3):202-210. PubMed ID: 34105702
[TBL] [Abstract][Full Text] [Related]
9. Sarcopenic Obesity in Chronic Kidney Disease: Challenges in Diagnosis Using Different Diagnostic Criteria.
Bellafronte NT; de Queirós Mattoso Ono A; Chiarello PG
Med Princ Pract; 2021; 30(5):477-486. PubMed ID: 34082433
[TBL] [Abstract][Full Text] [Related]
10. Chronic kidney disease and high eGFR according to body composition phenotype in adults with normal BMI.
Hyun YY; Lee KB; Rhee EJ; Park CY; Chang Y; Ryu S
Nutr Metab Cardiovasc Dis; 2016 Dec; 26(12):1088-1095. PubMed ID: 27776918
[TBL] [Abstract][Full Text] [Related]
11. The Importance of Muscle Versus Fat Mass in Sarcopenic Obesity: A Re-evaluation Using D3-Creatine Muscle Mass Versus DXA Lean Mass Measurements.
Orwoll ES; Peters KE; Hellerstein M; Cummings SR; Evans WJ; Cawthon PM
J Gerontol A Biol Sci Med Sci; 2020 Jun; 75(7):1362-1368. PubMed ID: 32436565
[TBL] [Abstract][Full Text] [Related]
12. Association of nutrition and immune-endocrine dysfunction with muscle mass and performance in cognitively impaired older adults.
Tay L; Leung BP; Wee S; Tay KS; Ali N; Chan M; Lim WS
Arch Gerontol Geriatr; 2018; 75():20-27. PubMed ID: 29172062
[TBL] [Abstract][Full Text] [Related]
13. Validation of a description of sarcopenic obesity defined as excess adiposity and low lean mass relative to adiposity.
Baker JF; Harris T; Rapoport A; Ziolkowski SL; Leonard MB; Long J; Zemel B; Weber DR
J Cachexia Sarcopenia Muscle; 2020 Dec; 11(6):1580-1589. PubMed ID: 32931633
[TBL] [Abstract][Full Text] [Related]
14. Strength measures are better than muscle mass measures in predicting health-related outcomes in older people: time to abandon the term sarcopenia?
Menant JC; Weber F; Lo J; Sturnieks DL; Close JC; Sachdev PS; Brodaty H; Lord SR
Osteoporos Int; 2017 Jan; 28(1):59-70. PubMed ID: 27394415
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of Sarcopenia and Relationships Between Muscle and Bone in Indian Men and Women.
Zengin A; Kulkarni B; Khadilkar AV; Kajale N; Ekbote V; Tandon N; Bhargava SK; Sachdev HS; Sinha S; Scott D; Kinra S; Fall CHD; Ebeling PR
Calcif Tissue Int; 2021 Oct; 109(4):423-433. PubMed ID: 33966094
[TBL] [Abstract][Full Text] [Related]
16. Sarcopenia-defining parameters, but not sarcopenia, are associated with cognitive domains in middle-aged and older European men.
Amini N; Dupont J; Lapauw L; Vercauteren L; Antonio L; O'Neill TW; Vanderschueren D; Pendleton N; Rastrelli G; Maggi M; Casanueva FF; Słowikowska-Hilczer J; Punab M; Huhtaniemi IT; Wu FCW; Verschueren S; Tournoy J; Gielen E
J Cachexia Sarcopenia Muscle; 2023 Jun; 14(3):1520-1532. PubMed ID: 37021434
[TBL] [Abstract][Full Text] [Related]
17. Osteosarcopenic obesity is associated with reduced handgrip strength, walking abilities, and balance in postmenopausal women.
Ilich JZ; Inglis JE; Kelly OJ; McGee DL
Osteoporos Int; 2015 Nov; 26(11):2587-95. PubMed ID: 26025288
[TBL] [Abstract][Full Text] [Related]
18. Assessment of muscle mass relative to fat mass and associations with physical functioning in rheumatoid arthritis.
Baker JF; Giles JT; Weber D; Leonard MB; Zemel BS; Long J; Ibrahim S; Katz PP
Rheumatology (Oxford); 2017 Jun; 56(6):981-988. PubMed ID: 28340012
[TBL] [Abstract][Full Text] [Related]
19. Associations of Sarcopenia and Sarcopenic Obesity With Metabolic Syndrome Considering Both Muscle Mass and Muscle Strength.
Lee J; Hong YP; Shin HJ; Lee W
J Prev Med Public Health; 2016 Jan; 49(1):35-44. PubMed ID: 26841883
[TBL] [Abstract][Full Text] [Related]
20. Low muscle mass and low muscle strength associate with nonalcoholic fatty liver disease.
Gan D; Wang L; Jia M; Ru Y; Ma Y; Zheng W; Zhao X; Yang F; Wang T; Mu Y; Zhu S
Clin Nutr; 2020 Apr; 39(4):1124-1130. PubMed ID: 31053512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
